Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jun 08, 2023 |
returned to senate passed assembly ordered to third reading rules cal.679 substituted for a1673a |
Jun 05, 2023 |
referred to ways and means delivered to assembly passed senate ordered to third reading cal.1451 committee discharged and committed to rules |
Jun 01, 2023 |
print number 1196a |
Jun 01, 2023 |
amend and recommit to finance |
May 22, 2023 |
reported and committed to finance |
Jan 10, 2023 |
referred to insurance |
Senate Bill S1196A
2023-2024 Legislative Session
Sponsored By
(D) 19th Senate District
Current Bill Status - Passed Senate & Assembly
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
Votes
Bill Amendments
co-Sponsors
(D) 15th Senate District
(D, WF) 55th Senate District
(D, WF) 17th Senate District
(D) 30th Senate District
2023-S1196 - Details
2023-S1196 - Sponsor Memo
BILL NUMBER: S1196 SPONSOR: PERSAUD TITLE OF BILL: An act to amend the insurance law and the social services law, in relation to requiring health insurance policies and medicaid to cover biomarker testing for certain purposes PURPOSE OR GENERAL IDEA OF BILL: This legislation will require that every state-regulated insurance plan, including Medicaid, provides coverage for biomarker testing when medically appropriate. SUMMARY OF PROVISIONS: Section 1 requires every individual accident and health insurance policy that provides coverage for medical, major medical, or similar comprehen- sive-type coverage shall provide coverage for biomarker testing for the purposes of diagnosis, treatment, appropriate management, or ongoing monitoring of a covered person's disease or condition. Defines criteria
2023-S1196 - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 1196 2023-2024 Regular Sessions I N S E N A T E January 10, 2023 ___________ Introduced by Sens. PERSAUD, BROUK, CLEARE, GOUNARDES, HOYLMAN-SIGAL, MANNION, MAY, MYRIE, THOMAS -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance AN ACT to amend the insurance law and the social services law, in relation to requiring health insurance policies and medicaid to cover biomarker testing for certain purposes THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 11-c to read as follows: (11-C) (A) EVERY POLICY WHICH PROVIDES MEDICAL, MAJOR MEDICAL, OR SIMILAR COMPREHENSIVE-TYPE COVERAGE SHALL PROVIDE COVERAGE FOR BIOMARKER TESTING FOR THE PURPOSES OF DIAGNOSIS, TREATMENT, APPROPRIATE MANAGE- MENT, OR ONGOING MONITORING OF A COVERED PERSON'S DISEASE OR CONDITION WHEN THE TEST IS SUPPORTED BY MEDICAL AND SCIENTIFIC EVIDENCE, INCLUD- ING, BUT NOT LIMITED TO: (I) LABELED INDICATIONS FOR A TEST APPROVED OR CLEARED BY THE FOOD AND DRUG ADMINISTRATION OF THE UNITED STATES GOVERNMENT OR INDICATED TESTS FOR A FOOD AND DRUG ADMINISTRATION APPROVED DRUG; (II) CENTERS FOR MEDICARE AND MEDICAID SERVICES NATIONAL COVERAGE DETERMINATIONS AND MEDICARE ADMINISTRATIVE CONTRACTOR LOCAL COVERAGE DETERMINATIONS; OR (III) NATIONALLY RECOGNIZED CLINICAL PRACTICE GUIDELINES AND CONSENSUS STATEMENTS. (B) SUCH COVERAGE SHALL BE PROVIDED IN A MANNER THAT SHALL LIMIT DISRUPTIONS IN CARE INCLUDING THE NEED FOR MULTIPLE BIOPSIES OR BIOSPE- CIMEN SAMPLES. (C) THE COVERED PERSON AND PRESCRIBING PRACTITIONER SHALL HAVE ACCESS TO A CLEAR, READILY ACCESSIBLE, AND CONVENIENT PROCESS TO REQUEST AN EXCEPTION TO A COVERAGE POLICY PROVIDED PURSUANT TO THE PROVISIONS OF EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD02625-01-3 S. 1196 2
co-Sponsors
(D) 15th Senate District
(D, WF) 55th Senate District
(R, C) 9th Senate District
(D, WF) 17th Senate District
2023-S1196A (ACTIVE) - Details
2023-S1196A (ACTIVE) - Sponsor Memo
BILL NUMBER: S1196A SPONSOR: PERSAUD TITLE OF BILL: An act to amend the insurance law and the social services law, in relation to requiring health insurance policies and medicaid to cover biomarker testing for certain purposes PURPOSE OR GENERAL IDEA OF BILL: This legislation will require that every state-regulated insurance plan, including Medicaid, provide coverage for biomarker testing when medically appropriate. SUMMARY OF PROVISIONS: Section 1 requires every individual accident and health insurance policy that provides coverage for medical, major medical, or similar comprehen- sive-type coverage shall provide coverage for biomarker testing for the purposes of diagnosis, treatment, appropriate management, or ongoing monitoring of a covered person's disease or condition. Defines criteria
2023-S1196A (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 1196--A 2023-2024 Regular Sessions I N S E N A T E January 10, 2023 ___________ Introduced by Sens. PERSAUD, ADDABBO, BROUK, CHU, CLEARE, COMRIE, COONEY, GALLIVAN, GIANARIS, GONZALEZ, GOUNARDES, GRIFFO, HARCKHAM, HELMING, HOYLMAN-SIGAL, KENNEDY, KRUEGER, MANNION, MATTERA, MAY, MYRIE, PALUMBO, PARKER, RIVERA, SALAZAR, SCARCELLA-SPANTON, SERRANO, SKOUFIS, STAVISKY, THOMAS, WEIK -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance -- reported favorably from said committee and committed to the Committee on Finance -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee AN ACT to amend the insurance law and the social services law, in relation to requiring health insurance policies and medicaid to cover biomarker testing for certain purposes THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 11-c to read as follows: (11-C) (A) EVERY POLICY WHICH PROVIDES MEDICAL, MAJOR MEDICAL, OR SIMILAR COMPREHENSIVE-TYPE COVERAGE SHALL PROVIDE COVERAGE FOR BIOMARKER TESTING FOR THE PURPOSES OF DIAGNOSIS, TREATMENT, APPROPRIATE MANAGE- MENT, OR ONGOING MONITORING OF A COVERED PERSON'S DISEASE OR CONDITION WHEN THE TEST PROVIDES CLINICAL UTILITY TO THE PATIENT AS DEMONSTRATED BY MEDICAL AND SCIENTIFIC EVIDENCE, INCLUDING, BUT NOT LIMITED TO: (I) LABELED INDICATIONS FOR A TEST APPROVED OR CLEARED BY THE FEDERAL FOOD AND DRUG ADMINISTRATION OR INDICATED TESTS FOR A FOOD AND DRUG ADMINISTRATION APPROVED DRUG; (II) CENTERS FOR MEDICARE AND MEDICAID SERVICES NATIONAL COVERAGE DETERMINATIONS AND MEDICARE ADMINISTRATIVE CONTRACTOR LOCAL COVERAGE DETERMINATIONS; OR (III) NATIONALLY RECOGNIZED CLINICAL PRACTICE GUIDELINES SUCH AS, BUT NOT LIMITED TO, THOSE OF THE NATIONAL COMPREHENSIVE CANCER NETWORK OR THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD02625-06-3
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.